Company intelligence / Profile preview

Hungarian Centre of Excellence for Molecular Medicine

Szeged, Csongrád-Csanád, Hungaryhcemm.eu ↗

Ownership: Private
Development stage: Other

Overview

HCEMM conducts cutting-edge biomedical and translational research focused on healthy ageing and major non-infectious age-associated diseases. It provides advanced core facilities to support high-quality science but does not have its own clinical pipeline or products.

Therapeutic areas: OncologyCardiovascularMetabolic DisordersImmunology
Modalities: DiagnosticsBiologicSmall moleculeRNA therapyProtein
Industry: Academic Hospital/University/Research

Partnerships

European Molecular Biology Laboratory (EMBL)—advanced partner for scientific collaboration and infrastructure sharingNational Research Development & Innovation Office Hungary—project coordination/funding

Beyond the preview

Go deeper on Hungarian Centre of Excellence for Molecular Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hungarian Centre of Excellence for Molecular Medicine.

Explore the full profile